Shingo Kyotani

6.6k total citations · 2 hit papers
61 papers, 4.7k citations indexed

About

Shingo Kyotani is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Shingo Kyotani has authored 61 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 40 papers in Cardiology and Cardiovascular Medicine and 9 papers in Surgery. Recurrent topics in Shingo Kyotani's work include Pulmonary Hypertension Research and Treatments (47 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiovascular Issues in Pregnancy (15 papers). Shingo Kyotani is often cited by papers focused on Pulmonary Hypertension Research and Treatments (47 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiovascular Issues in Pregnancy (15 papers). Shingo Kyotani collaborates with scholars based in Japan, United States and Norway. Shingo Kyotani's co-authors include Norifumi Nakanishi, Noritoshi Nagaya, Toru Satoh, Fumio Sakamaki, Kunio Miyatake, Masaaki Uematsu, Yoshiaki Okano, Kenji Kangawa, Toshio Nishikimi and Masatoshi Fujita and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shingo Kyotani

60 papers receiving 4.5k citations

Hit Papers

Clinical Correlates and Prognostic Significance of Six-mi... 2000 2026 2008 2017 2000 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shingo Kyotani Japan 32 3.6k 2.9k 637 546 537 61 4.7k
Norifumi Nakanishi Japan 38 5.9k 1.6× 4.6k 1.6× 1.1k 1.8× 923 1.7× 943 1.8× 116 7.7k
Hiromi Matsubara Japan 40 3.4k 0.9× 3.7k 1.3× 906 1.4× 687 1.3× 200 0.4× 196 5.5k
Ari Chaouat France 41 7.6k 2.1× 3.2k 1.1× 1.1k 1.7× 716 1.3× 595 1.1× 138 8.6k
Nobuhiro Tanabe Japan 33 2.5k 0.7× 1.5k 0.5× 481 0.8× 301 0.6× 299 0.6× 214 3.6k
Koichiro Sugimura Japan 29 1.5k 0.4× 1.5k 0.5× 341 0.5× 276 0.5× 161 0.3× 104 2.5k
Sven Günther France 21 1.8k 0.5× 1.0k 0.3× 355 0.6× 302 0.6× 125 0.2× 62 2.3k
Edmund Lau Australia 26 2.3k 0.6× 1.2k 0.4× 344 0.5× 330 0.6× 242 0.5× 89 2.7k
Hani Shennib Canada 28 2.6k 0.7× 1.4k 0.5× 183 0.3× 1.4k 2.6× 188 0.4× 76 3.7k
Georg Hansmann Germany 37 3.0k 0.9× 1.6k 0.5× 227 0.4× 900 1.6× 1.4k 2.6× 127 4.8k
Ichizo Tsujino Japan 30 1.7k 0.5× 1.1k 0.4× 187 0.3× 441 0.8× 311 0.6× 127 2.9k

Countries citing papers authored by Shingo Kyotani

Since Specialization
Citations

This map shows the geographic impact of Shingo Kyotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Kyotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Kyotani more than expected).

Fields of papers citing papers by Shingo Kyotani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Kyotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Kyotani. The network helps show where Shingo Kyotani may publish in the future.

Co-authorship network of co-authors of Shingo Kyotani

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Kyotani. A scholar is included among the top collaborators of Shingo Kyotani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Kyotani. Shingo Kyotani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Funasako, Moritoshi, et al.. (2010). Abstract 19627: Long-Term Epoprostenol Infusion Therapy Could Induce Hyperthyroidism in Patients With Idiopathic and Hereditary Pulmonary Arterial Hypertension. Circulation. 122. 1 indexed citations
2.
Utsunomiya, Hiroto, Satoshi Nakatani, Hideaki Kanzaki, et al.. (2009). Value of Estimated Right Ventricular Filling Pressure in Predicting Cardiac Events in Chronic Pulmonary Arterial Hypertension. Journal of the American Society of Echocardiography. 22(12). 1368–1374. 31 indexed citations
3.
Amaki, Makoto, Satoshi Nakatani, Hideaki Kanzaki, et al.. (2009). Usefulness of three-dimensional echocardiography in assessing right ventricular function in patients with primary pulmonary hypertension. Hypertension Research. 32(5). 419–422. 13 indexed citations
4.
Kouzu, Hidemichi, Satoshi Nakatani, Shingo Kyotani, et al.. (2009). Noninvasive Estimation of Pulmonary Vascular Resistance by Doppler Echocardiography in Patients With Pulmonary Arterial Hypertension. The American Journal of Cardiology. 103(6). 872–876. 51 indexed citations
5.
Kyotani, Shingo. (2006). 1 Management of Continuous Intravenous Prostacyclin therapy for Pulmonary arterial Hypertension(Which drug is useful for the treatment of pulmonary hypertension?,Topic 4 (TP4) (M),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society). Japanese Circulation Journal-english Edition. 70. 64–65. 1 indexed citations
6.
Matsuda, Hitoshi, Hitoshi Ogino, Kenji Minatoya, et al.. (2006). Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension. The Annals of Thoracic Surgery. 82(4). 1338–1343. 70 indexed citations
7.
Kataoka, Masaharu, Noritoshi Nagaya, Toru Satoh, et al.. (2005). A Long-Acting Prostacyclin Agonist with Thromboxane Inhibitory Activity for Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 172(12). 1575–1580. 40 indexed citations
8.
Satoh, Toru, Shingo Kyotani, Yoshiaki Okano, Norifumi Nakanishi, & Takeyoshi Kunieda. (2004). Descriptive patterns of severe chronic pulmonary hypertension by chest radiography. Respiratory Medicine. 99(3). 329–336. 16 indexed citations
9.
Nagaya, Noritoshi, Noriko Sasaki, Motomi Ando, et al.. (2003). Prostacyclin Therapy Before Pulmonary Thromboendarterectomy in Patients With Chronic Thromboembolic Pulmonary Hypertension*. CHEST Journal. 123(2). 338–343. 143 indexed citations
10.
Nakanishi, Mamoru, Yoshikazu Takanami, Taro Maruyama, et al.. (2003). The Ratio of Serum Paraoxonase/Arylesterase Activity Using an Improved Assay for Arylesterase Activity to Discriminate PON1R192 from PON1Q192. Journal of Atherosclerosis and Thrombosis. 10(6). 337–342. 33 indexed citations
11.
Ono, Fumiaki, Noritoshi Nagaya, Hiroyuki Okumura, et al.. (2003). Effect of Orally Active Prostacyclin Analogue on Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension Without Major Vessel Obstruction. CHEST Journal. 123(5). 1583–1588. 67 indexed citations
12.
Nagaya, Noritoshi, Motomi Ando, Hideo Oya, et al.. (2002). Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy. The Annals of Thoracic Surgery. 74(1). 180–184. 74 indexed citations
13.
Nagaya, Noritoshi, Masaaki Uematsu, Hideo Oya, et al.. (2001). Short-term Oral Administration of l- Arginine Improves Hemodynamics and Exercise Capacity in Patients with Precapillary Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 163(4). 887–891. 152 indexed citations
14.
Nakayama, Yasunori, Norifumi Nakanishi, Tomoshige Hayashi, et al.. (2001). Pulmonary artery reflection for differentially diagnosing primary pulmonary hypertension and chronic pulmonary thromboembolism. Journal of the American College of Cardiology. 38(1). 214–218. 52 indexed citations
15.
Miyamoto, Shoichi, Noritoshi Nagaya, Toru Satoh, et al.. (2000). Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension: Comparison with Cardiopulmonary Exercise Testing. American Journal of Respiratory and Critical Care Medicine. 161(2). 487–492. 857 indexed citations breakdown →
16.
Nagaya, Noritoshi, Masaaki Uematsu, Toru Satoh, et al.. (1999). Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 160(2). 487–492. 211 indexed citations
17.
Nagaya, Noritoshi, Masaaki Uematsu, Yoshiaki Okano, et al.. (1999). Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. Journal of the American College of Cardiology. 34(4). 1188–1192. 156 indexed citations
18.
Takamoto, Shinichi, Yutaka Okita, Ritsu Matsukawa, et al.. (1998). Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. The Annals of Thoracic Surgery. 66(6). 1919–1924. 26 indexed citations
19.
Nagaya, Noritoshi, Toshio Nishikimi, Masaaki Uematsu, et al.. (1998). Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. American Heart Journal. 136(2). 297–301. 70 indexed citations
20.
Nakayama, Yasunori, Norifumi Nakanishi, Masaru Sugimachi, et al.. (1997). Characteristics of Pulmonary Artery Pressure Waveform for Differential Diagnosis of Chronic Pulmonary Thromboembolism and Primary Pulmonary Hypertension. Journal of the American College of Cardiology. 29(6). 1311–1316. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026